2013 FDA Approval
After an extensive on-site review, the FDA has determined that GRAM meets all requirements for production of parenteral drug products, both aseptically filled and terminally sterilized.
After an extensive on-site review, the FDA has determined that GRAM meets all requirements for production of parenteral drug products, both aseptically filled and terminally sterilized.
As biologic therapies continue to reshape pharmaceutical development, the demands placed on sterile fill-finish manufacturing have never been higher. Pharmaceutical...
The sterile manufacturing industry is undergoing a significant transformation as regulatory agencies shift towards a comprehensive approach to compliance. GRAM...
The company is enhancing its U.S. sterile fill-finish contract manufacturing services to meet growing industry demand for prefilled syringes and...